New Delhi, July 28 -- Torrent Pharmaceuticals Ltd aims to be in the first wave of generic launches of Novo Nordisk's weight-loss drugs Wegovy and Ozempic in Brazil starting next year, the company's management said on Monday, without sharing exact timelines.

1 (glucagon-like peptide-1) compound which is sold under brand names Wegovy and Ozempic, is set to go off patent in key markets, including India and Brazil, in March 2026. Indian generic players are gearing up to cash in on the blockbuster opportunity.

While declining to share the company's specific plans, Sanjay Gupta, Torrent Pharma's head of international business, told investors in a post-earnings call that the Ahmedabad-based drugmaker is planning generic launches for both Ozemp...